Please login to the form below

Not currently logged in
Email:
Password:

Astellas promotes John Demaree

He becomes vice president of oncology marketing, Americas

Astellas John DemareeAstellas has appointed John Demaree as vice president of oncology marketing for its Americas operations.

In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

Prior to joining Astellas in 2011, Demaree served as the general manager for oncology business development and alliance management at Abbott, and also brings experience from Eli Lilly and Novartis.

Mark Reisenauer, senior vice president of the oncology business unit for Astellas Americas, said: “Astellas is committed to making a difference in the lives of cancer patients through an emphasis on innovation and R&D.

“We are confident that John's commercial experience in oncology will help us make strides in improving care for the patients we serve.”

22nd July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

How Far Do You Want To Go?
Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
"Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....

Infographics